ProAct, Inc., is proud to have been awarded the 2025 Excellence Award for Cost Containment by the Pharmacy Benefit Management Institute (PBMI).
This award demonstrates ProAct’s commitment to innovative solutions that empower clients to offer robust pharmacy benefits while keeping costs under control – never compromising on quality or service.
"It is an honor for ProAct to be recognized in the cost containment category at the 2025 PBMI National Conference,” says Deborah Dempsey, MBA, Pharm.D., RPh, ProAct’s Chief Operating Officer. “ProAct's cost containment strategy supports and validates what our employee owners do every day, to help plan sponsors offer a comprehensive pharmacy benefit while responsibly managing plan spend."
About PBMI
The Pharmacy Benefit Management Institute is the industry's only membership organization exclusively dedicated to helping healthcare purchasers maximize the value of their drug benefit plans. Since 1995, PBMI has provided valuable research, education, web resources, and a forum to advance best practices and drive marketplace changes that improve pharmacy benefits and control costs.
About ProAct, Inc.
ProAct, Inc., is a 100% employee-owned pharmacy benefit management (PBM) company. ProAct is a part of the KPH Healthcare Services family of companies, which includes Kinney Drugs. ProAct empowers clients to take charge of their pharmacy benefit plans by combining high-touch service with the latest in PBM technology. ProAct manages the dispensing of prescription drugs through its mail order pharmacy, ProAct Pharmacy Services, as well as through its national retail pharmacy network consisting of over 64,000 pharmacies in the United States, Puerto Rico, Guam, and the Virgin Islands. For more information, visit www.proactrx.com.
Media Contact
Amanda Pendock
Senior Marketing Lead
amandapendock@proactrx.com
